Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
for Hidradenitis Suppurativa (HS)
Drug: Povorcitinib
25 locations incl. Birmingham
Sponsor: Incyte Corporation
Sex: All·Age: 12 - 17
Code: NCT07213973·Phase 2·Recruiting